Study
Higher Thiamine Intake May Lower Type 2 Diabetes Risk in Adults Over 45
A study suggests that increased thiamine intake is linked to a lower likelihood of developing type 2 diabetes in adults aged 45 and older.
Summary
In plain language
Recent research indicates that adults over 45 who consume more thiamine, a type of vitamin B1, may have a lower risk of developing type 2 diabetes. The study reviewed data from over 15,000 participants aged 45 and up, examining their dietary habits and health outcomes. Findings showed that those with higher thiamine intake had a reduced incidence of type 2 diabetes. While thiamine is found in foods like whole grains and certain meats, the study highlights the potential benefits of ensuring adequate intake to support glucose metabolism. Seniors should consider discussing their thiamine levels and dietary sources with healthcare providers to understand how it fits into their overall health plan.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study used data from the National Health and Nutrition Examination Survey (NHANES) to explore the link between thiamine intake and type 2 diabetes in adults 45 and older.
The research included over 15,000 participants who reported their food intake, focusing on thiamine levels, and were assessed for type 2 diabetes.
Results indicated a trend where higher thiamine intake was associated with a lower incidence of type 2 diabetes, suggesting its potential protective role.
It's important to note that while the findings are promising, other factors like lifestyle and overall diet also play a role, and further studies are needed for conclusive evidence.
Seniors should consider discussing their diet, including thiamine-rich foods, with their healthcare providers to better manage diabetes risk.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Higher Thiamine Intake May Lower Type 2 Diabetes Risk in Adults Over 45
Published September 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored September 28, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study is a cross-sectional analysis using NHANES data, which limits its design score. Bias control is minimal due to the observational nature. Statistical methods are standard but lack power analysis. Transparency is moderate with adherence to STROBE guidelines. Conflicts are well-managed with no competing interests. The study is relevant to the target population and published in a high-quality journal, but lacks replication evidence.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 3.3/10 | |
| Bias control | 3.3/10 | |
| Statistical methods | 5.0/10 | |
| Reporting completeness | 5.0/10 | |
| Conflicts & funding | 10.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This cross-sectional study investigates the association between dietary thiamine intake and type 2 diabetes risk in US adults aged 45 and older using NHANES data. It finds an inverse relationship, suggesting higher thiamine intake may reduce diabetes risk.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Dietary Management
Dietary management focuses on making thoughtful food choices to maintain good health, prevent disease, and manage chronic conditions. For seniors, balanced nutrition supports energy, mobility, and overall well-being while helping manage blood pressure, cholesterol, and digestion.
Thiamine (Vitamin B1)
Thiamine supports energy metabolism, nerve health, and cognitive function, helping maintain steady vitality.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.